Literature DB >> 17414701

Changes in coronary arterial dimensions early after cardiac transplantation.

William F Fearon1, Luciano Potena, Atsushi Hirohata, Ryota Sakurai, Masao Yamasaki, Helen Luikart, Julia Lee, Marcy L Vana, John P Cooke, Edward S Mocarski, Alan C Yeung, Hannah A Valantine.   

Abstract

BACKGROUND: Significant changes in coronary artery structure, including intimal thickening and vessel remodeling, occur early after cardiac transplantation. The degree to which these changes compromise coronary lumen dimensions, and the clinical factors that affect these changes, remain controversial.
METHODS: Thirty-eight adult cardiac transplant recipients underwent coronary angiography and volumetric intravascular ultrasound (IVUS) evaluation of the left anterior descending artery within 8 weeks of transplantation and at 1 year. Clinical parameters including donor and recipient characteristics, rejection episodes, and serology were prospectively recorded. Two-dimensional IVUS measurements and vessel, lumen and plaque volume were calculated at both time points and compared. Multivariate regression analysis was performed to reveal clinical predictors of change in coronary dimensions.
RESULTS: During the first year after transplantation, significant decreases in vessel size (negative remodeling) and lumen size were observed with significant increases in plaque burden based on IVUS analyses. Loss of lumen volume correlated significantly with the degree of negative remodeling (R=0.82, P<0.0001), but not with changes in plaque burden (R=0.08, P=0.64). Patients with the greatest increase in plaque volume had significantly less negative remodeling (R=0.53, P=0.0006). Transplant recipient cytomegalovirus (CMV) antibody seropositivity and lack of aggressive prophylaxis against CMV infection/reactivation were significant independent predictors of greater negative remodeling (P<0.01 and P=0.03, respectively) and greater lumen loss (P=0.02 and P=0.03, respectively).
CONCLUSION: Negative remodeling is primarily responsible for coronary artery lumen loss during the first year after cardiac transplantation. CMV seropositivity and lack of aggressive CMV prophylaxis correlate with increased negative remodeling, resulting in greater lumen loss.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17414701     DOI: 10.1097/01.tp.0000256335.84363.9b

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  11 in total

1.  Scaling of Engineered Vascular Grafts Using 3D Printed Guides and the Ring Stacking Method.

Authors:  Cameron B Pinnock; Zhengfan Xu; Mai T Lam
Journal:  J Vis Exp       Date:  2017-03-27       Impact factor: 1.355

Review 2.  New developments in the management of cytomegalovirus infection after solid organ transplantation.

Authors:  Albert J Eid; Raymund R Razonable
Journal:  Drugs       Date:  2010-05-28       Impact factor: 9.546

3.  Significant increase in 1-year posttransplant renal arterial index predicts graft loss.

Authors:  Mélanie Terebus Loock; Jamal Bamoulid; Cécile Courivaud; Philippe Manzoni; Dominique Simula-Faivre; Jean-Marc Chalopin; Bruno Kastler; Didier Ducloux
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-08       Impact factor: 8.237

4.  Human cytomegalovirus-specific T-cell immune reconstitution in preemptively treated heart transplant recipients identifies subjects at critical risk for infection.

Authors:  Davide Abate; Marta Fiscon; Alda Saldan; Simona Cofano; Carlo Mengoli; Dino Sgarabotto; Chiara d'Agostino; Luisa Barzon; Riccardo Cusinato; Giuseppe Toscano; Giuseppe Feltrin; Antonio Gambino; Gino Gerosa; Giorgio Palù
Journal:  J Clin Microbiol       Date:  2012-03-29       Impact factor: 5.948

5.  Cytomegalovirus enhances macrophage TLR expression and MyD88-mediated signal transduction to potentiate inducible inflammatory responses.

Authors:  Phillip D Smith; Masako Shimamura; Lois C Musgrove; Evida A Dennis; Diane Bimczok; Lea Novak; Mary Ballestas; Anne Fenton; Satya Dandekar; William J Britt; Lesley E Smythies
Journal:  J Immunol       Date:  2014-10-29       Impact factor: 5.422

Review 6.  Diagnosis and management of coronary allograft vasculopathy in children and adolescents.

Authors:  Nathalie Dedieu; Gerald Greil; James Wong; Matthew Fenton; Michael Burch; Tarique Hussain
Journal:  World J Transplant       Date:  2014-12-24

7.  Incidence, risk factors, and outcomes of delayed-onset cytomegalovirus disease in a large, retrospective cohort of heart transplant recipients.

Authors:  C A Q Santos; D C Brennan; V J Fraser; M A Olsen
Journal:  Transplant Proc       Date:  2014-12       Impact factor: 1.066

Review 8.  Preserving and evaluating hearts with ex vivo machine perfusion: an avenue to improve early graft performance and expand the donor pool.

Authors:  Michael J Collins; Sina L Moainie; Bartley P Griffith; Robert S Poston
Journal:  Eur J Cardiothorac Surg       Date:  2008-06-06       Impact factor: 4.191

Review 9.  Cytomegalovirus Hyper Immunoglobulin for CMV Prophylaxis in Thoracic Transplantation.

Authors:  Federico Rea; Luciano Potena; Nizar Yonan; Florian Wagner; Fiorella Calabrese
Journal:  Transplantation       Date:  2016-03       Impact factor: 4.939

10.  Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients.

Authors:  Inger Johansson; Rune Andersson; Vanda Friman; Nedim Selimovic; Lars Hanzen; Salmir Nasic; Ulla Nyström; Vilborg Sigurdardottir
Journal:  BMC Infect Dis       Date:  2015-12-24       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.